https://www.selleckchem.com/pr....oducts/climbazole.ht
stered on 12 January 2018. ClinicalTrials.gov NCT03397836 . Registered on 12 January 2018. Studies have investigated risk factors for infections by specific species of carbapenem-resistant Gram-negative bacilli (CR-GN, but few considered the group of GNB species and most of them were performed in the setting of bacteremia or hospital infection. This study was implemented to identify risk factors for sepsis by CR- and carbapenem-susceptible (CS) GNB in intensive care unit (ICU) patients to improve management strategies for CR-GNB se
Like
Comment
Share
